We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$8.61B
AUM Growth
-$1.09B
Cap. Flow
-$352M
Cap. Flow %
-4.08%
Top 10 Hldgs %
30.78%
Holding
207
New
16
Increased
51
Reduced
80
Closed
30

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$58.4M
2
BSX icon
Boston Scientific
BSX
+$41.2M
3
PACB icon
Pacific Biosciences
PACB
+$38.3M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$37.2M
5
CDNA icon
CareDx
CDNA
+$32.9M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$109M
2
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$75.3M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$73.9M
4
DHR icon
Danaher
DHR
+$66.3M
5
HUM icon
Humana
HUM
+$65.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.39%
2 Industrials 0.69%
3 Energy 0.03%
4 Technology 0.01%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BILI icon
176
Bilibili
BILI
$7.18B
$19K ﹤0.01%
+744
New +$23.9K
PDD icon
177
Pinduoduo
PDD
$118B
$19K ﹤0.01%
+466
New +$23.9K
A icon
178
Agilent Technologies
A
$39.1B
– –
-1,000
Closed -$160K
AXP icon
179
American Express
AXP
$223B
– –
-1,500
Closed -$245K
CLLS
180
Cellectis
CLLS
$286M
– –
-82,500
Closed -$670K
CLX icon
181
Clorox
CLX
$11.6B
– –
-1,200
Closed -$209K
CYBR
182
DELISTED
CyberArk
CYBR
– –
-2,100
Closed -$364K
DGX icon
183
Quest Diagnostics
DGX
$25.1B
– –
-15,250
Closed -$2.64M
EA icon
184
Electronic Arts
EA
$52.4B
– –
-2,270
Closed -$299K
ENTG icon
185
Entegris
ENTG
$19.7B
– –
-3,000
Closed -$416K
FTNT icon
186
Fortinet
FTNT
$112B
– –
-4,015
Closed -$289K
GGG icon
187
Graco
GGG
$12.9B
– –
-4,500
Closed -$363K
NBP
188
NovaBridge Biosciences American Depositary Shares
NBP
$205M
– –
-144,957
Closed -$6.87M
JD icon
189
JD.com
JD
$40.8B
– –
-3,600
Closed -$252K
LLY icon
190
Eli Lilly
LLY
$1.07T
– –
-7,552
Closed -$2.09M
LYV icon
191
Live Nation Entertainment
LYV
$41.2B
– –
-4,700
Closed -$563K
MASI
192
DELISTED
Masimo
MASI
– –
-131,376
Closed -$38.5M
MKL icon
193
Markel Group
MKL
$25B
– –
-300
Closed -$370K
NEO icon
194
NeoGenomics
NEO
$1.81B
– –
-469,695
Closed -$16M
NVAX icon
195
Novavax
NVAX
$1.23B
– –
-10,400
Closed -$1.49M
NYT icon
196
New York Times
NYT
$11.6B
– –
-7,500
Closed -$362K
OLED icon
197
Universal Display
OLED
$3.71B
– –
-1,365
Closed -$225K
OSCR icon
198
Oscar Health
OSCR
$8.5B
– –
-679,952
Closed -$5.34M
SPOT icon
199
Spotify
SPOT
$99.2B
– –
-1,100
Closed -$257K
STNE icon
200
StoneCo
STNE
$2.62B
– –
-4,300
Closed -$72K
5 6 7
8
9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q1 2022 Portfolio in Review

As of Q1 2022, Bellevue Group held 207 positions worth $8.61B, down 11% from $9.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Group withdrew a net $352M in Q1 2022, closing 30 positions and reducing 80 holdings. Its most notable exit was VOCERA COMMUNICATIONS, INC., an estimated $75.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Industrials and Energy.

Against the trend, Bellevue Group opened a new position in Aurinia Pharmaceuticals worth $29.8M.

  • Bellevue Group's largest Q1 2022 buy was Aurinia Pharmaceuticals: 2,405,825 shares worth $29.8M.
  • Bellevue Group added most to Outset Medical in Q1 2022, an estimated $58.4M increase.
  • Bellevue Group's biggest Q1 2022 reduction was Biogen, cutting an estimated $109M.
  • Bellevue Group fully exited VOCERA COMMUNICATIONS, INC. in Q1 2022, selling an estimated $75.3M.
  • Bellevue Group's ten largest holdings make up 31% of its $8.61B portfolio in Q1 2022.
  • Bellevue Group opened 16 new positions and closed 30 in Q1 2022.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $8.61B.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.